NPPA notified regarding the fixation and revision of the ceiling price of certain formulations

Oct 16, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on October 14, 2024, issued a notification regarding the fixation and revision of the ceiling price of certain formulations.

The following has been stated namely: -

• For each film-coated tablet containing: Bisoprolol Fumarate IP 2.5 mg + Amlodipine Besilate IP eq. to Amlodipine 5 mg is Rs. 6.23/-

• For Gentamicin and Dexamethasone Eye Drops (1ml) is Rs. 2.01/-

• For each 2.5 ml respule containing: Levosalbutamol Sulphate IP eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide IP eq. to Ipratropium (Anhydrous) 500 mcg is Rs. 5.75/-

The detailed notification is given in the document below.

[Notification No. S.O. 4497(E)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT